RX-207, a Small Molecule Inhibitor of Protein Interaction with Glycosaminoglycans (SMIGs), Reduces Experimentally Induced Inflammation and Increases Survival Rate in Cecal Ligation and Puncture (CLP)-Induced Sepsis
Language English Country United States Media print
Document type Journal Article
Grant support
ITMS 26220120066
ERDF
PubMed
29110154
DOI
10.1007/s10753-017-0688-0
PII: 10.1007/s10753-017-0688-0
Knihovny.cz E-resources
- Keywords
- glycosaminoglycan, heparin binding protein, inflammation, neutrophil, sepsis,
- MeSH
- Anti-Inflammatory Agents pharmacology MeSH
- Cell Adhesion drug effects MeSH
- Cecum microbiology surgery MeSH
- Quinazolinones pharmacology MeSH
- Edema chemically induced metabolism pathology prevention & control MeSH
- Glycosaminoglycans metabolism MeSH
- Neutrophil Infiltration drug effects MeSH
- Ligation MeSH
- Disease Models, Animal MeSH
- Mice, Inbred BALB C MeSH
- Neutrophils drug effects metabolism microbiology MeSH
- Pancreatitis chemically induced metabolism pathology prevention & control MeSH
- Peritonitis chemically induced metabolism pathology prevention & control MeSH
- Punctures MeSH
- Sepsis metabolism microbiology pathology prevention & control MeSH
- Protein Binding MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Inflammatory Agents MeSH
- Quinazolinones MeSH
- Glycosaminoglycans MeSH
The fused quinazolinone derivative, RX-207, is chemically and functionally related to small molecule inhibitors of protein binding to glycosaminoglycans (SMIGs). Composed of a planar aromatic amine scaffold, it inhibits protein binding to glycosaminoglycans (GAGs). RX-207 reduced neutrophil migration in thioglycollate-induced peritonitis (37%), inhibited carrageenan-induced paw edema (32%) and cerulein-induced pancreatitis (28%), and increased animal survival in the mouse model of cecal ligation and puncture (CLP)-induced sepsis (60%). The mechanism of RX-207 action, analyzed by UV spectroscopy, confirmed that which was elucidated for chemically related anti-inflammatory SMIGs. RX-207 binding to cell surface GAGs can account for the inhibition of neutrophil recruitment via the micro-vasculature and as a consequence, the reduction of neutrophil mediated tissue damage in the animal models of inflammation and improved survival of mice in CLP-induced sepsis.
GISMO Therapeutics Inc A253 ASTECC UK Lexington KY 40506 USA
GYN FIV a s Záhradnícka 42 821 085 Bratislava Slovakia
Institute of Animal Physiology Slovak Academy of Sciences 04001 Kosice Slovakia
Rimonyx Pharmaceuticals Ltd Rabin Science Park 70400 Ness Ziona Israel
See more in PubMed
Gastroenterology. 1985 May;88(5 Pt 1):1192-204 PubMed
Fed Proc. 1987 Jan;46(1):118-26 PubMed
J Biol Chem. 2000 Nov 3;275(44):34818-25 PubMed
Crit Care Nurs Q. 2015 Apr-Jun;38(2):121-36 PubMed
Phys Chem Chem Phys. 2015 Oct 14;17(38):24560-5 PubMed
Nat Rev Drug Discov. 2014 Oct;13(10):741-58 PubMed
J Surg Res. 1990 Aug;49(2):186-96 PubMed
Inflamm Res. 2009 Sep;58(9):553-60 PubMed
BMJ. 2016 May 23;353:i1585 PubMed
Exp Biol Med (Maywood). 2016 May;241(10 ):1042-53 PubMed
Ann Intern Med. 1985 May;102(5):576-80 PubMed
J Crit Care. 2015 Dec;30(6):1156-62 PubMed
Intensive Care Med Exp. 2016 Dec;4(1):33 PubMed
Shock. 2002 May;17 (5):416-22 PubMed
Mucosal Immunol. 2012 Jul;5(4):354-66 PubMed
Pharmacol Rev. 2000 Sep;52(3):349-74 PubMed
Shock. 2015 Dec;44(6):569-77 PubMed
Immunopharmacol Immunotoxicol. 2015;37(4):400-12 PubMed
Trends Mol Med. 2014 Apr;20(4):195-203 PubMed
Biomed Res Int. 2016;2016:3758278 PubMed
Crit Care Nurs Clin North Am. 2011 Mar;23(1):29-39 PubMed
Eur J Immunol. 1997 Jun;27(6):1580-3 PubMed
Nat Med. 2001 Oct;7(10):1123-7 PubMed
J Exp Med. 1993 Apr 1;177(4):1205-8 PubMed
Annu Rev Pathol. 2006;1:467-96 PubMed
Toxicol Appl Pharmacol. 2012 Oct 15;264(2):182-91 PubMed
Nat Immunol. 2011 Jun 26;12(8):761-9 PubMed
Shock. 2010 Sep;34 Suppl 1:27-33 PubMed
Nat Rev Immunol. 2013 Mar;13(3):159-75 PubMed
Inflamm Res. 2016 Apr;65(4):285-94 PubMed
Nat Rev Immunol. 2011 Jul 25;11(8):519-31 PubMed
Biochim Biophys Acta. 2014 Jan;1840(1):245-54 PubMed
J Vis Exp. 2014 Feb 09;(84):e51066 PubMed
Nat Immunol. 2014 Jul;15(7):602-11 PubMed
Eur J Pharmacol. 2000 Nov 17;408(2):199-211 PubMed
Blood. 2003 Jul 1;102(1):328-35 PubMed